Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Neuland Laboratories Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value(
)
524558
INE794A01010
1081.5200264
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
NEULANDLAB
69.26
18219.02
EPS(TTM)
Face Value(
)
Div & Yield %:
205.02
10
0.1
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
1558.58
1191.20
951.08
936.91
762.71
666.83
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1558.58
1191.20
951.08
936.91
762.71
666.83
Other Income
12.54
9.75
2.08
16.09
3.89
3.49
Stock Adjustments
55.14
9.51
15.41
1.24
11.16
-5.80
Total Income
1626.26
1210.46
968.57
954.24
777.76
664.52
EXPENDITURE :
Raw Materials
636.49
491.98
441.79
443.04
394.41
363.03
Power & Fuel Cost
48.72
48.62
42.21
39.21
32.75
26.81
Employee Cost
248.53
194.84
175.76
144.02
118.48
104.47
Other Manufacturing Expenses
103.73
82.69
84.92
73.71
61.79
47.51
Selling & Administrative Expenses
104.29
88.50
70.50
79.80
51.76
52.57
Miscellaneous Expenses
10.04
22.77
9.12
11.93
13.21
8.76
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1151.81
929.40
824.29
791.71
672.41
603.16
Operating Profit
474.47
281.06
144.27
162.54
105.34
61.36
Interest
14.00
13.07
13.49
17.90
21.57
15.66
Gross Profit
460.47
267.99
130.78
144.64
83.77
45.70
Depreciation
59.70
52.78
49.04
39.68
31.28
25.86
Profit Before Tax
400.77
215.21
81.74
104.96
52.49
19.84
Tax
99.59
50.39
20.42
12.48
0.00
5.44
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
1.59
1.70
-2.22
12.18
36.62
-1.75
Reported Net Profit
299.60
163.12
63.53
80.29
15.88
16.14
Extraordinary Items
-0.30
-0.66
-1.36
9.81
0.12
-0.09
Adjusted Net Profit
299.90
163.78
64.89
70.48
15.76
16.23
Adjustment below Net Profit
0.00
0.00
0.00
0.00
-0.18
0.00
P & L Balance brought forward
460.54
303.84
244.15
166.42
155.67
139.53
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
12.83
6.41
3.85
2.57
4.95
0.00
P & L Balance carried down
747.31
460.54
303.84
244.15
166.42
155.67
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
140.00
100.00
50.00
50.00
20.00
0.00
Dividend Per Share(Rs)
14.00
10.00
5.00
5.00
2.00
0.00
Earnings Per Share-Unit Curr
232.24
126.44
49.25
62.24
12.31
12.51
Earnings Per Share(Adj)-Unit Curr
232.24
126.44
49.25
62.24
12.31
12.51
Book Value-Unit Curr
988.88
765.49
647.06
605.44
546.26
538.54
Book Value(Adj)-Unit Curr
988.88
765.49
647.06
605.44
546.26
538.54